Evaluation and treatment of central pain syndromes

Neurology

Volumn 62, Issue 5 SUPPL. 2, 2004, Pages

  Nicholson, Bruce D ^a,b  

^a Lehigh Valley Hosp and Hlth Netwk   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; BACLOFEN; BENZODIAZEPINE DERIVATIVE; BOTULINUM TOXIN; CARBAMAZEPINE; CLONAZEPAM; DANTROLENE; DIAZEPAM; GABAPENTIN; LAMOTRIGINE; LIDOCAINE; MEXILETINE; MORPHINE; OPIATE; SPASMOLYTIC AGENT; TIZANIDINE; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT;

ALLODYNIA; ANTICHOLINERGIC EFFECT; BRAIN DEPTH STIMULATION; BRAIN INJURY; CLINICAL FEATURE; CONFERENCE PAPER; CORDOTOMY; DISEASE CLASSIFICATION; DOSE RESPONSE; HUMAN; MUSCLE WEAKNESS; NAUSEA; NERVE TRANSECTION; NEUROPATHIC PAIN; PAIN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEDATION; SIDE EFFECT; SOMNOLENCE; SPASTICITY; SPINAL CORD INJURY; STROKE; TENOTOMY; VOMITING;

EID: 1542286071     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.62.5_suppl_2.s30     Document Type: Conference Paper

References (43)

1. Tasker RR. Central pain states. In: Loeser JD, ed. Bonica's management of pain. Philadelphia: Lippincott Williams & Wilkins, 2001:432-453.
2. National Spinal Cord Injury Statistical Center. Spinal cord injury - Facts and figures at a glance. Birmingham, AL, 2001. Available at: http://www.spinalcord.uab.edu. Accessed February 18, 2003.
3. Bonica JJ. Introduction: semantic, epidemiologic, and educational issues. In: Casey KL, ed. Pain and central nervous system disease: the central pain syndromes. New York: Raven Press, 1991:13-29.
4. Bouhassira D, Attal N, Brasseur L, Parker F. Quantitative sensory testing in patients with painful or painless syringomyelia. In: Devore M, Rowbotham MC, Wiesenfeld-Hallin Z, eds. Proceedings of the 9th World Congress on Pain. Progress in pain research and management. Vol. 16. Seattle: IASP Press, 2000:401-410.
5. Eide PK. Pathophysiological mechanisms of central neuropathic pain after spinal cord injury. Spinal Cord 1998;36:601-612.
6. American Heart Association. Heart disease and stroke statistics-2003 update. Dallas: American Heart Association; 2002. Available at: http://www.americanheart.org/downloadable/heart/1040391091015HDS_Stats_03.pdf. Accessed February 17, 2003.
7. Jensen TS, Lenz FA. Central post-stroke pain: a challenge for the scientist and the clinician. Pain 1995;61:161-164.
8. Andersen G, Vestergaard K, Ingemann-Nielsen M, Jensen TS. Incidence of central poststroke pain. Pain 1995;61:187-193.
9. Bowsher D. Some population data about central poststroke pain. Proc 9th World Congr Pain 1999:435. Abstract.
10. Leijon G, Boivie J, Johansson I. Central post-stroke pain - neurological symptoms and pain characteristics. Pain 1989;36:13-25.
11. Bowsher D, Leijon G, Thuomas KA. Central poststroke pain: correlation of MRI with clinical pain characteristics and sensory abnormalities. Neurology 1998;51:1352-1358.
12. Dostrovsky J, Manduch M, Davis K, Tasker R, Lozano A. Thalamic stimulation-evoked pain and temperature sites in pain and non-pain patients. 9th World Congr Pain. Progress in pain research and management. 2000:419-425.
13. Siddall PJ, Yezierski RP, Loeser JD. Pain following spinal cord injury: clinical features, prevalence, and taxonomy. IASP Newsletter 2000. Available at: http://www.iasp.pain.org/TC00-3.html.
14. McHenry KW. Lessons from my central pain. Pain Clinical Updates. International Association for the Study of Pain 2002 Sept;10(3). Available at http://www.iasp-pain.org/PCU02-3.html.
15. Attal N, Guirimand V, Brasseur L, et al. Intravenous lidocaine in central pain: a double-blind, placebo-controlled, psychophysical study. Neurology 2000;54:564-574.
16. Attal N, Guirimand F, Brasseur L, Gaude V, Chauvin M, Bouhassira D. Effects of IV morphine in central pain: a randomized placebo-controlled study. Neurology 2002;58:554-563.
17. Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999;353:1959-1964.
18. Leijon G, Boivie J. Central post-stroke pain - a controlled trial of amitriptyline and carbamazepine. Pain 1989;36:27-36.
19. American Geriatrics Society. The management of persistent pain in older persons. J Am Geriatr Soc 2002;50:205-224.
20. Vestergaard K, Andersen G, Gottrup H, Kristensen BT, Jensen TS. Lamotrigine for central poststroke pain: a randomized controlled trial. Neurology 2001;56:184-190.
21. Finnerup NB, Sindrup SH, Bach FW, Johannesen IL, Jensen TS. Lamotrigine in spinal cord injury pain: a randomized controlled trial. Pain 2002;96:375-383.
22. Eisenberg E, Lurie Y, Braker C, Daoud D, Ishay A. Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study. Neurology 2001;57:505-509.
23. Brodie MJ. Lamotrigine. Lancet 1992;339:1397-1400.
24. Tai Q, Kirshblum S, Chen B, Millis S, Johnston M, DeLisa JA. Gabapentin in the treatment of neuropathic pain after spinal cord injury: a prospective, randomized, double-blind, crossover trial. J Spinal Cord Med 2002;25:100-105.
25. Canavero S, Bonicalzi V, Paolotti R. Lack of effect of topiramate for central pain. Neurology 2002;58:831-832.
26. Finnerup NB, Yezierski RP, Sang CN, Burchial KJ, Jensen TS. Treatment of spinal cord injury pain. Pain Clinical Updates. International Association for the Study of Pain 2001 June;9(2). Available at: http://www.iasp-pain.org/PCU01-2.html.
27. Melzack R, Wall PD. Pain mechanisms: a new theory. Science 1965;150: 971-979.
28. Linderoth B, Stiller CO, Gunasekera L, et al. Release of neurotransmitters in the CNS by spinal cord stimulation: survey of present state of knowledge and recent experimental studies. Stereotact Funct Neurosurg 1993;61:157-170.
29. Stiller CO, Cui JG, O'Connor WT, Brodin E, Meyerson BA, Linderoth B. Release of gamma-aminobutyric acid in the dorsal horn and suppression of tactile allodynia by spinal cord stimulation in mononeuropathic rats. Neurosurgery 1996;39:367-375.
30. Katayama Y, Yamamoto T, Kobayashi K, Kasai M, Oshima H, Fukaya C. Motor cortex stimulation for post-stroke pain: comparison of spinal cord and thalamic stimulation. Stereotact Funct Neurosurg 2001;77:183-186.
31. Maruno N, Kaminaga T, Mikami M, Furui S. Activation of supplementary motor area during imaginary movement of phantom toes. Neurorehab Neural Repair 2000;14:345-349.
32. Roux FE, Ibarrola D, Lazorthes Y, Berry I. Chronic motor cortex stimulation for phantom limb pain: a functional magnetic resonance imaging study: technical case report. Neurosurgery 2001;48:681-688.
33. Gelber DA, Good DC. Management of spasticity. Stroke Clinical Updates 2000 Aug;10(5); Englewood, CO: National Stroke Association.
34. O'Brien CF, Seeberger LC, Smith DB. Spasticity after stroke. Epidemiology and optimal treatment. Drugs Aging 1996;9:332-340.
35. Gracies JM, Nance P, Elovic E, McGuire J, Simpson DM. Traditional pharmacological treatments for spasticity, Part II: General and regional treatments. Muscle Nerve Suppl 1997;6:S92-120.
36. Meythaler JM, Guin-Renfroe S, Johnson A, Brunner RM. Prospective assessment of tizanidine for spasticity due to acquired brain injury. Arch Phys Med Rehab 2001b;82:1155-1163.
37. Gelber DA, Good DC, Dromerick A, Sergay S, Richardson M. Open-label dose-titration safety and efficacy study of tizanidine hydrochloride in the treatment of spasticity associated with chronic stroke. Stroke 2001; 32:1841-1846.
38. Gelber DA, Josefczyk PB, Therapeutics in the management of spasticity. Neural Ablation Neural Repair 1999;13:5-14.
39. Gruenthal M, Mueller M, Olson WL, Priebe MM, Sherwood AM, Olson WH. Gabapentin for the treatment of spasticity in patients with spinal cord injury. Spinal Cord 1997;35:686-689.
40. Brashear A, Gordon MF, Elovic E, et al. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. N Engl J Med 2002;347:395-400.
41. Wang HC, Hsieh LF, Chi WC, Lou SM. Effect of intramuscular botulinum toxin injection on upper limb spasticity in stroke patients. Am J Phys Med Rehab 2002;81:272-278.
42. Gwartz BL, Intrathecal baclofen for spasticity caused by thrombotic stroke. Am J Phys Med Rehab 2001;80:383-387.
43. Meythaler JM, Guin-Renfroe S, Brunner RC, Hadley MN. Intrathecal baclofen for spastic hypertonia from stroke. Stroke 2001a;32:2099-2109.